TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Accounts Payables (2020 - 2025)

Updated

TFA Therapeutics (RAJAF) reported Accounts Payables of $365,140 for Q4 2025, up 32.2% from $276,125 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Accounts Payables (2020 - 2025) Analysis & Trends

Dating back to Q4 2020, TFA Therapeutics' Accounts Payables record includes 6 quarters.

  • Accounts Payables has a five-year compound annual growth rate of 394.9% (FY2020 to FY2025).
  • By year, Accounts Payables came in at $276,125 in FY2024 (+48.9%), $185,434 in FY2023 and $111,696 in FY2021.
  • The Q4 2025 figure ranks as the highest quarterly Accounts Payables since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Procter & Gamble 386.76 Bn 342.52 Bn 10.28 Bn 16.31 Bn
2 Colgate Palmolive 76.15 Bn 70.88 Bn 3.30 Bn 2.12 Bn
3 Estee Lauder Companies 37.55 Bn 25.63 Bn 2.74 Bn 1.58 Bn
4 Kenvue 36.95 Bn 32.56 Bn 2.30 Bn 2.58 Bn
5 Kimberly Clark 35.82 Bn 33.02 Bn 1.60 Bn 3.37 Bn
6 Church & Dwight 25.13 Bn 23.66 Bn 693.90 Mn 775.90 Mn
7 Clorox 10.44 Bn 8.71 Bn 804.00 Mn 1.60 Bn
8 e.l.f. Beauty 6.63 Bn 5.60 Bn 398.84 Mn 95.92 Mn
9 Reynolds Consumer Products 4.82 Bn 4.49 Bn 245.00 Mn 433.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - 365,140.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 365,140.00
Dec 31, 2024 276,125.00
Dec 31, 2023 185,434.00
Sep 30, 2023 1.37 Mn
Dec 31, 2021 111,696.00
Dec 31, 2020 123.00
API Access

TFA Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RAJAF&period=max&api_key=YOUR_API_KEY